tiprankstipranks
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market
KALV
KalVista Pharmaceuticals
RESEARCH TOOLSreports
Want to see KALV full AI Analyst Report?

KalVista Pharmaceuticals (KALV) Stock News & Sentiment

616 Followers
KalVista Downgraded to $27 Target as Chiesi’s All-Cash Takeout Caps Near-Term Upside, Supporting Hold Rating
Premium
Ratings
KalVista Downgraded to $27 Target as Chiesi’s All-Cash Takeout Caps Near-Term Upside, Supporting Hold Rating
7d ago
KALV
Chiesi to Acquire KalVista Pharmaceuticals in Cash Merger
Premium
Company Announcements
Chiesi to Acquire KalVista Pharmaceuticals in Cash Merger
7d ago
8K
KALV
3 ‘Strong Buy’ Stocks With Up to 180% Upside to Buy Now, According to Top Analysts, 4/16/2026
Premium
Market News
3 ‘Strong Buy’ Stocks With Up to 180% Upside to Buy Now, According to Top Analysts, 4/16/2026
20d ago
ACRS
KALV
Ekterly: Strong Global Launch Momentum and Pediatric Upside Support Multi‑Year Growth and $39 Price Target
Premium
Ratings
Ekterly: Strong Global Launch Momentum and Pediatric Upside Support Multi‑Year Growth and $39 Price Target
30d ago
KALV
Sustained EKTERLY Uptake and Shift Toward Oral HAE Therapy Underpin Buy Rating on KalVista
Premium
Ratings
Sustained EKTERLY Uptake and Shift Toward Oral HAE Therapy Underpin Buy Rating on KalVista
1M ago
KALV
Early Outperformance and Expanding On‑Demand HAE Opportunity Justify Buy Rating on KalVista
Premium
Ratings
Early Outperformance and Expanding On‑Demand HAE Opportunity Justify Buy Rating on KalVista
2M ago
KALV
KalVista’s Pediatric HAE Trial for Sebetralstat Reaches Completion, Setting Up a Key Catalyst for KALV
Premium
Company Announcements
KalVista’s Pediatric HAE Trial for Sebetralstat Reaches Completion, Setting Up a Key Catalyst for KALV
3M ago
KALV
More KALV News >

KALV News on the Web

KalVista Pharmaceuticals (KALV) Leads Short Interest Among Small-Cap Stocks
GuruFocus News
Neutral
3 ‘Strong Buy’ Stocks With Up to 180% Upside to Buy Now, According to Top Analysts, 4/16/2026
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), KalVista Pharmaceuticals (KALV)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), KalVista Pharmaceuticals (KALV) and TScan Therapeutics (TCRX)
TipRanks News
Neutral
Squadron Capital Management LLC Acquires 7,608,695 Shares in SCYNEXIS Inc
GuruFocus News
Neutral
Ekterly: Strong Global Launch Momentum and Pediatric Upside Support Multi‑Year Growth and $39 Price Target
TipRanks News
Neutral
KalVista announces interim Phase 3 data from KONFIDENT-KID trial of EKTERLY
TipRanks News
Neutral
KalVista Pharmaceuticals (KALV) Gets a Buy from Stifel Nicolaus
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
KALV
Sector Average
Media Buzz
This Week5 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KALV’s Media Buzz Sentiment?
5 articles about KALV were published this week. In an average week, 3.5 articles are published.
    What is KALV’s weekly average amount of articles?
    In an average week, 3.5 articles about KALV are published.
      What is KALV’s News Sentiment?
      100% of articles about KALV were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week